FMI estimated the nanobot drug delivery implants market was valued at USD 84.5 million in 2025. The industry is poised to reach USD 96.0 million in 2026. Nanofluidic membrane implants are expected to lead by Technology platform with 31.0% share in 2026, and Biodegradable polymer implants are likely to dominate by Implant material through 2036.